Archives
-
DiscoveryProbe™ Metabolism-related Compound Library
2026-09-29
The DiscoveryProbe™ Metabolism-related Compound Library provides a standardized set of metabolism-focused small molecules for enzyme, pathway, and cell-based screening. It is intended for in vitro and ex vivo research, not for clinical, diagnostic, or unvalidated in vivo use.
-
N1-Methylpseudouridine Supports Faithful mRNA Translation
2026-09-29
The reference study shows that N1-methylpseudouridine has little detectable effect on ribosomal decoding accuracy, tRNA selection, or the production of miscoded peptides in tested systems. These findings support the use of modified RNA in mRNA vaccine development while also distinguishing translational fidelity from broader properties such as RNA half-life, innate immune activation, and delivery.
-
Sulfo-Cy3 Azide for Neurodevelopmental Mapping
2026-09-28
A translational strategy for applying Sulfo-Cy3 azide as a water-compatible bioconjugation reagent in spatial neurodevelopmental assays, using Nurr1 patterning and EdU birth dating as a model for rigorous experimental design.
-
Adefovir (GS-0393) Research Workflows
2026-09-28
Use Adefovir to investigate selective HBV polymerase inhibition or, in a separate assay, OAT1-mediated transport. This workflow distinguishes established product data from practical optimization suggestions, helping researchers choose concentrations, handle the compound in water, and interpret results in the context of each model.
-
Direct Mouse Genotyping Kit Plus: Workflow & Evidence
2026-09-27
The Direct Mouse Genotyping Kit Plus (K1027) combines tissue lysis with direct PCR and a PCR master mix with dye reagents, reducing the need for separate DNA purification. This article distinguishes the kit’s stated workflow from peer-reviewed findings on liver-metastasis macrophages, which provide biological context but do not validate the kit.
-
N1-Methylpseudo-UTP: Use, Evidence & Handling
2026-09-26
N1-Methyl-Pseudouridine-5'-Triphosphate (N1-Methylpseudo-UTP) is a modified nucleotide intended for incorporation into RNA during in vitro transcription. Product information describes its use for RNA stability and translation research, while the cited R2 retrotransposon study addresses DNA insertion repair—not this nucleotide’s performance.
-
MCC950 Sodium and Coagulation in Endotoxemia
2026-09-25
MCC950 sodium is a selective tool for testing how NLRP3 contributes to inflammation and coagulation during endotoxemia. This article examines a time-resolved mouse study to show why cytokine suppression, tissue factor-positive extracellular vesicles, and coagulation should be measured as distinct outcomes.
-
From Myosin Inhibition to Organ-Scale Cardiac Insight
2026-09-25
Transparent cardiac arrays can reveal electrical and metabolic activity across the beating heart; selective myosin inhibition adds a complementary way to test how cytoskeletal force contributes to those signals. This article connects (-)-Blebbistatin’s mechanism to translational experimental design, while distinguishing established platform findings from proposed compound-enabled studies.
-
KX2-391: Testing Src Dependence in Fibrotic Signaling
2026-09-24
KX2-391 dihydrochloride is a dual-action research compound that can help investigate Src-dependent signaling—but its tubulin activity makes experimental interpretation critical. This article connects its pharmacology to recent liver-fibrosis research while distinguishing a useful hypothesis from established evidence.
-
EZ Cap™ Cas9 mRNA (5-moUTP) for Fyn–Stat3 Studies
2026-09-24
Pair a capped, modified Cas9 mRNA with guide RNA to test gene function in CRISPR-Cas9 workflows inspired by zebrafish neurodegeneration research. The article separates the study’s demonstrated Fyn–Stat3 findings from practical, proposed editing applications and provides handling, optimization, and troubleshooting guidance.
-
Amiloride (MK-870) for Reliable Cell Assays
2026-09-23
Learn how to use Amiloride (MK-870), SKU BA2768, as a controlled perturbation in viability, proliferation, and ion-transport experiments. This practical guide distinguishes product specifications from workflow recommendations and explains controls that help prevent overinterpreting assay signals.
-
Icatibant in Viral Infections: Evidence and Limits
2026-09-23
The reference letter reframes icatibant as a mechanism-based intervention and pharmacologic probe for viral diseases involving bradykinin-driven vascular leakage. Its synthesis of hantavirus case reports and an early COVID-19 trial supports further evaluation, but the evidence remains heterogeneous and does not establish efficacy across viral syndromes.
-
ICAA, RIP3, and Angiotensin II Cardiac Hypertrophy
2026-09-22
The reference study identifies receptor-interacting protein 3 (RIP3/RIPK3) as a direct molecular target of isochlorogenic acid A (ICAA) in angiotensin II- and pressure overload-induced cardiac hypertrophy. Its findings connect RIP3 inhibition to reduced CaMKII signaling while showing that this remodeling effect is independent of MLKL, providing a distinct mechanistic framework for cardiovascular disease research.
-
PD 173074: A Translational FGFR1/VEGFR2 Probe
2026-09-22
PD 173074 is most valuable when used as a causal pharmacology tool rather than treated as a generic multidrug-resistance reversal agent. Its selective FGFR1 and VEGFR2 activity enables researchers to separate receptor-kinase biology, angiogenesis, tumor-cell dependence, and ABC transporter behavior in translational cancer models.
-
KX2-391 Dihydrochloride: Applied Workflow Guide
2026-09-21
KX2-391 dihydrochloride combines substrate-site Src inhibition with tubulin-polymerization disruption, enabling coordinated oncology assays rather than single-readout screening. This workflow also shows how to evaluate its differentiated HBV transcription and BoNT/A inhibitor applications while controlling solubility, exposure, and mechanism-specific confounders.